Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells
Author:
Kumar Naresh1, Dey Chinmoy S.1
Affiliation:
1. Signal Transduction Research Laboratory, Department of Biotechnology,National Institute of Pharmaceutical Education and Research, Punjab,India
Abstract
SUMMARY
Sulfonylurea drugs are used in the treatment of type 2 diabetes. The mechanism of action of sulfonylureas is to release insulin from pancreatic cells and they have been proposed to act on insulin-sensitive tissues to enhance glucose uptake. The goal of the present study was to test the hypothesis that gliclazide, a second-generation sulfonylurea, could enhance insulin signaling in insulin-resistant skeletal muscle cells. We demonstrated that gliclazide enhanced insulin-stimulated insulin receptor tyrosine phosphorylation in insulin-resistant skeletal muscle cells. Although insulin receptor substrate-1 tyrosine phosphorylation was unaffected by gliclazide treatment, phosphatidylinositol 3-kinase activity was partially restored by treatment with gliclazide. No increase in 2-deoxyglucose uptake in insulin-resistant cells by treatment with gliclazide was observed. Further investigations into the mitogen-activated protein kinase (MAPK) pathway revealed that insulin-stimulated p38 phosphorylation was impaired, as compared with extracellular-signal-regulated kinase (ERK) and c-Jun N-terminal kinase(JNK), which were phosphorylated normally in insulin-resistant cells. Treatment with gliclazide could not restore p38 phosphorylation in insulin-resistant cells. We propose that gliclazide can regulate part of the insulin signaling in insulin-resistant skeletal muscle, and p38 could be a potential therapeutic target for glucose uptake to treat insulin resistance.
Publisher
The Company of Biologists
Subject
Insect Science,Molecular Biology,Animal Science and Zoology,Aquatic Science,Physiology,Ecology, Evolution, Behavior and Systematics
Reference35 articles.
1. Aguirre, V., Uchida, T., Yenush, L., Davis, R. and White, M. F. (2000). The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J. Biol. Chem.275,9047-9054. 2. Bak, J. F., Schmitz, O., Sorensen, N. S. and Pederson, O.(1989). Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic subjects. Diabetes38,1343-1350. 3. Clancy, B. M., Harrison, S. A., Buxton, J. M. and Czech, M. P. (1991). Protein synthesis inhibitors activate glucose transport without increasing plasma membrane glucose transporters in 3T3-L1 adipocytes. J. Biol. Chem.266,10122-10130. 4. Cooper, D. R., Vila, M. C., Watson, J. E., Nair, G., Pollet, R. J., Standaert, M. and Farese, R. V. (1990). Sulfonylurea-stimulated glucose transport association with diacylglycerol like activation of protein kinase C in BC3H1 myocytes. Diabetes39,1399-1407. 5. Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E.,Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R. and Mandarino, L. J.(2000). Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Invest.105,311-320.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|